Cloning & Mutagenesis Market
The global cloning & mutagenesis market size reached US$ 2.8 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 10.3 Billion by 2032, exhibiting a growth rate (CAGR) of 15.6% during 2024-2032. The rising prevalence of chronic and genetic disorders, the escalating demand for personalized medicines, and the increasing utilization of GMOs in agriculture and medicine represent some of the key factors driving the market.
Read More-https://www.imarcgroup.com/cloning-mutagenesis-market
The global cloning & mutagenesis market size reached US$ 2.8 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 10.3 Billion by 2032, exhibiting a growth rate (CAGR) of 15.6% during 2024-2032. The rising prevalence of chronic and genetic disorders, the escalating demand for personalized medicines, and the increasing utilization of GMOs in agriculture and medicine represent some of the key factors driving the market.
Read More-https://www.imarcgroup.com/cloning-mutagenesis-market
Cloning & Mutagenesis Market
The global cloning & mutagenesis market size reached US$ 2.8 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 10.3 Billion by 2032, exhibiting a growth rate (CAGR) of 15.6% during 2024-2032. The rising prevalence of chronic and genetic disorders, the escalating demand for personalized medicines, and the increasing utilization of GMOs in agriculture and medicine represent some of the key factors driving the market.
Read More-https://www.imarcgroup.com/cloning-mutagenesis-market
0 Comments
0 Shares
284 Views
0 Reviews